Bloomberg Podcasts · Ryanair Gains on Narrower Net Loss; Regeneron Melanoma Trial Failure | Stock Movers

1. 1. NextEra Energy is acquiring Dominion Energy in a significant $67 billion all-stock deal, which will create a major East Coast utility titan.
2. 2. Dominion Energy's stock soared 15% following the announcement of its acquisition by NextEra Energy.
3. 3. Ryanair's CEO expressed "almost zero concerns" about the airline's jet fuel supplies for the upcoming summer despite broader industry anxieties.
4. 4. Ryanair has hedged 80% of its jet fuel requirements until April of next year at approximately $67 per barrel.
5. 5. Regeneron's late-stage trial for a skin cancer treatment failed to achieve its primary objective, causing the biopharma company's stock to fall 12%.
6. 6. Investors are growing increasingly impatient with Regeneron due to the recent drug trial failure, which follows another drug test failure last year.